Insiders who reported open-market trades in the last 12 months at the companies Sean Mackay files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Sean Mackay is a corporate insider, tracked as SVP & Chief Business Officer of STANDARD BIOTOOLS INC. (LAB). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sean Mackay submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Sean Mackay been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($38K) across all tracked filings.
Sean Mackay is SVP & Chief Business Officer of STANDARD BIOTOOLS INC. (LAB). 10 SEC Form 4 filings on record going back to 2025, most recently on 24 August 2026. Most recent open-market trade: sold $12K of LAB on 23 May 2025. Lifetime open-market sales: $38K.
Recent transactions
11
The latest 11 SEC Form 4 transactions reported by Sean Mackay.
InsiderAlpha's records for Sean Mackay go back to 2025: 10 primary Form 4 filings, an average of 5.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
